MedPath

Survey of migraine in headache disorders -based on receipt data of health insurance insured persons and questionnaire survey

Not Applicable
Conditions
Migraine
Registration Number
JPRN-UMIN000045002
Lead Sponsor
Otsuka Pharmaceuticals Co., Ltd
Brief Summary

Analysis of 21,480 population showed that the prevalence of migraine was 3.2%, 4.4 times higher in women than in men, and higher in patients aged 30-39 years. Among migraine patients, 81.0% have not visited a hospital, more than 80% were taking over-the-counter medications, and 6.1% were taking prescription medications only. About 52.9% of the patients reported that the intensity of their pain symptoms was "severe" and 72.9% reported moderate or greater impairment in activities of daily living.

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
21704
Inclusion Criteria

Not provided

Exclusion Criteria

None

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Daily life impairment and health-related QOL of migraine Trouble with a headache(reasons for stopping taking migraine medication and reasons for forgetting to take it) Burden of people with headaches (daily life / visiting a health care institution) Prevalence of migraine and other headache disorders Percentage of visiting a health care institution for migraine and other headache diseases Status of taking migraine remedies
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath